Sphera Funds Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.31M | Hold |
9,040
| – | – | 1.32% | 18 |
|
|
2025
Q4 | $9.72M | Sell |
9,040
-1,000
| -10% | -$956K | 1.88% | 11 |
|
|
2025
Q3 | $7.66M | Sell |
10,040
-1,500
| -13% | -$1.12M | 1.62% | 15 |
|
|
2025
Q2 | $9M | Sell |
11,540
-150
| -1% | -$117K | 2.11% | 10 |
|
|
2025
Q1 | $9.65M | Sell |
11,690
-1,500
| -11% | -$1.25M | 2.22% | 10 |
|
|
2024
Q4 | $10.2M | Hold |
13,190
| – | – | 1.84% | 12 |
|
|
2024
Q3 | $11.7M | Hold |
13,190
| – | – | 1.86% | 15 |
|
|
2024
Q2 | $11.9M | Sell |
13,190
-1,000
| -7% | -$800K | 1.63% | 17 |
|
|
2024
Q1 | $11M | Hold |
14,190
| – | – | 1.55% | 21 |
|
|
2023
Q4 | $8.27M | Hold |
14,190
| – | – | 1.33% | 26 |
|
|
2023
Q3 | $7.62M | Sell |
14,190
-1,500
| -10% | -$773K | 1.39% | 17 |
|
|
2023
Q2 | $7.36M | Sell |
15,690
-16,000
| -50% | -$6.71M | 1.15% | 27 |
|
|
2023
Q1 | $10.9M | Buy |
31,690
+6,000
| +23% | +$2.02M | 1.82% | 14 |
|
|
2022
Q4 | $9.4M | Sell |
25,690
-117,860
| -82% | -$41.8M | 2.02% | 13 |
|
|
2022
Q3 | $46.4M | Buy |
143,550
+11,300
| +9% | +$3.58M | 6.44% | 3 |
|
|
2022
Q2 | $42.9M | Buy |
132,250
+61,955
| +88% | +$18.6M | 4.59% | 5 |
|
|
2022
Q1 | $20.1M | Sell |
70,295
-89,400
| -56% | -$23M | 2.85% | 12 |
|
|
2021
Q4 | $44.1M | Sell |
159,695
-188,800
| -54% | -$47.9M | 4.85% | 4 |
|
|
2021
Q3 | $80.5M | Buy |
348,495
+166,600
| +92% | +$41.1M | 6.76% | 1 |
|
|
2021
Q2 | $41.7M | Sell |
181,895
-247,305
| -58% | -$49.7M | 2.82% | 10 |
|
|
2021
Q1 | $80.2M | Buy |
429,200
+19,200
| +5% | +$3.76M | 6.15% | 1 |
|
|
2020
Q4 | $69.2M | Buy |
410,000
+254,000
| +163% | +$37.9M | 6.14% | 1 |
|
|
2020
Q3 | $23.1M | Buy |
156,000
+66,000
| +73% | +$10.2M | 2.27% | 11 |
|
|
2020
Q2 | $14.8M | Buy |
+90,000
| New | +$13.8M | 1.39% | 19 |
|
|
2016
Q4 | – | Sell |
-200,000
| Closed | -$16.1M | – | 116 |
|
|
2016
Q3 | $16.1M | Hold |
200,000
| – | – | 2.61% | 7 |
|
|
2016
Q2 | $15.8M | Buy |
+200,000
| New | +$15.1M | 4.09% | 5 |
|
|
2015
Q1 | – | Sell |
-87,100
| Closed | -$6.01M | – | 159 |
|
|
2014
Q4 | $6.01M | Sell |
87,100
-10,000
| -10% | -$675K | 1.02% | 24 |
|
|
2014
Q3 | $6.3M | Sell |
97,100
-2,900
| -3% | -$184K | 0.78% | 33 |
|
|
2014
Q2 | $6.22M | Sell |
100,000
-200,000
| -67% | -$11.9M | 1.53% | 15 |
|
|
2014
Q1 | $17.7M | Buy |
+300,000
| New | +$16.7M | 4.03% | 7 |
|
Other funds holding LLY
VCM
VPM
Sphera Funds Management's LLY Position: Q1 2026 in Review
Sphera Funds Management held its Eli Lilly (LLY) position steady in Q1 2026 at 9,040 shares worth $8.31M. The position accounts for 1.32% of the portfolio, ranked #18.
Sphera Funds Management first reported a position in LLY in Q1 2014 and has held it in 30 quarters since. The position peaked at $80.5M in Q3 2021. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sphera Funds Management held 9,040 shares of Eli Lilly worth $8.31M as of Q1 2026.
- Sphera Funds Management left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 1.32% of Sphera Funds Management's portfolio in Q1 2026, its #18 holding.
- Sphera Funds Management first reported a position in Eli Lilly in Q1 2014 and has held it in 30 quarters since.
- Sphera Funds Management's Eli Lilly position peaked at $80.5M in Q3 2021.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.